Catechin-free tea water and composition containing same
US-2017007535-A1 · Jan 12, 2017 · US
US11318180B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11318180-B2 |
| Application number | US-201816765823-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 24, 2018 |
| Priority date | Nov 20, 2017 |
| Publication date | May 3, 2022 |
| Grant date | May 3, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed in the present application are: a composition containing a green tea extract comprising at least one selected from the group consisting of 7 wt % or more of polysaccharides, less than 20 wt % of catechins, and 10 wt % or more of dietary fibers, relative to a total weight of the green tea extract, the composition having a use for blood glucose control; and a method for preparing the composition. The composition has not only effects of inhibiting activity of glucosidase and amylase but also effects of lowering blood glucose by inhibiting the glucose uptake in small intestinal cells.
Opening claim text (preview).
The invention claimed is: 1. A method for regulating blood glucose, the method comprising: administering an effective amount of a composition comprising a green tea extract comprising 7 wt % or more of a polysaccharide, less than 20 wt % of catechin and 10 wt % or more of a dietary fiber based on the total weight of the green tea extract to a subject in need of blood glucose regulation. 2. The method according to claim 1 , wherein the green tea extract further comprises less than 7 wt % of a monosaccharide and a disaccharide based on the total weight of the green tea extract. 3. The method according to claim 1 , wherein the green tea extract comprises 9 wt % or more of a polysaccharide based on the total weight of the green tea extract. 4. The method according to claim 1 , wherein the green tea extract comprises 13 wt % or more of a dietary fiber based on the total weight of the green tea extract. 5. The method according to claim 1 , wherein the composition lowers blood glucose. 6. The method according to claim 1 , wherein the composition inhibits carbohydrate digestion and glucose uptake in small intestine cells. 7. The method according to claim 6 , wherein the inhibition of carbohydrate digestion is achieved by inhibiting the activity of amylase or glucosidase. 8. The method according to claim 1 , wherein the green tea extract is a hot-water extract obtained by hot-water extracting an extraction residue of an extract obtained by adding an alcohol or an aqueous alcohol solution to green tea as a first solvent. 9. The method according to claim 8 , wherein the green tea extract is an alcohol or aqueous alcohol solution precipitate of the hot-water extract. 10. The method according to claim 1 , wherein the composition is a pharmaceutical composition. 11. The method according to claim 1 , wherein the composition is a food composition.
Plant extracts, their artificial duplicates or their derivatives · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Theaceae (Tea family), e.g. camellia · CPC title
using mixed solvents, e.g. 70% EtOH · CPC title
having effect on glycaemic control and diabetes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.